Concepedia

Author

Amber B. Clemmons

University of GeorgiaORCID

Also Known As

A B Clemmons, A. Clemmons, Amber B Clemmons, Amber B. Clemmons, Amber B. Clemmons, PharmD, BCOP, Amber Bradley Clemmons, Amber Clemmons, Amber Clemmons, PharmD, BCOP, Clemmons Amber B, Stephen Clark

50

Publications

478

Citations

14

H-Index

32

Concepts

All Affiliations

University of GeorgiaAugusta UniversityGeorgia College & State UniversityGeorgia Regents Medical CenterAugusta University Health
AB

About

Amber B. Clemmons is an author at University of Georgia specializing in medicine, oncology, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

106

2

Health Sciences

2

2

37

3

Public Health

1

1

13

4

Blood Transplantation

1

1

15

5

Cellular Therapies

1

1

15

Amber B. Clemmons

×

11

Publications

246

Citations

11

H-Index

YearCitations

Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial

Amber B. Clemmons, Julianne Orr, Benjamin Andrick,

Biology of Blood and Marrow Transplantation

2018

54

Development and implementation of a writing program to improve resident authorship rates

Amber B. Clemmons, Stephanie C. Hoge, Ashley Cribb,

American Journal of Health-System Pharmacy

2015

26

Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime

Amber B. Clemmons, Christine Flagstad Bech, Jeremy Pantin,

Biology of Blood and Marrow Transplantation

2017

25

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Megan E. Hartranft, Amber B. Clemmons, David L. DeRemer,

Journal of Oncology Pharmacy Practice

2015

24

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Morgan Gwynn, David L. DeRemer, Katherine Saunders,

Journal of Oncology Pharmacy Practice

2019

22

Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Emily Behren Ketchum, Andrea Clarke, Amber B. Clemmons

Journal of the Advanced Practitioner in Oncology

2022

22

Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center

Rachael McCaleb, Arpita Shah Gandhi, Stephen M. Clark,

Annals of Pharmacotherapy

2016

18

Mixed outpatient–inpatient autologous stem cell transplant for multiple myeloma: A cost-saving initiative in a resource constrained environment

Amber B. Clemmons, Samm Anderegg

Journal of Oncology Pharmacy Practice

2016

15

Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia

Amber B. Clemmons, Henry N. Young, Christopher M. Bland,

Diagnostic Microbiology and Infectious Disease

2021

15

Impact of the COVID-19 pandemic on faculty at research-intensive United States schools/colleges of pharmacy

Amber B. Clemmons, Lisa Lebovitz, Kayleigh Greene,

Currents in Pharmacy Teaching and Learning

2021

13

Page 1